Skip to main content
Premium Trial:

Request an Annual Quote

Following Nanogen Investment, Jurilab Says it Expects Additional Funding from Undisclosed Parties

NEW YORK, July 26 (GenomeWeb News) - Jurilab expects several million dollars worth of additional funding from undisclosed parties within the next several months, on top of the $3 million investment from Nanogen announced on Tuesday, GenomeWeb News has learned.


Nanogen has so far invested $1.5 million in the Finnish pharmacogenomics company, giving it an approximately 20-percent equity interest in Jurilab, and will add another $1.5 million within six months.


As a result of the expected additional funding, Nanogen's equity interest in Jurilab after the second investment tranche will total less than 25 percent, not close to 40 percent as previously reported, according to a company spokesperson.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.